Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b Trial of BMS-955176 With Tenofovir/Emtricitabine in Treatment-Naive HIV-1 Infected Adults
2013-005487-26Phase 2Terminated
- Sponsor
- ViiV Healthcare
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BMS-955176 in Human immunodeficiency virus infection type 1 (4 arms), sponsored by ViiV Healthcare. Primary endpoint: Virologic suppression at Week 24. Started Jun 2015; status: terminated.
02
Drugs
BMS-955176
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2013-005487-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005487-26.